GlassScriptPhysician profile
Wesley Greene
NPI 1154997526
$3,978.59
in general payments reported to CMS, 2019-2025
10 companies · $3,130 in 2025
The $3,130 reported for 2025 was more than what 94% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $157 · 2023: $220 · 2024: $471 · 2025: $3,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,303 · Travel and Lodging: $1,519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,302.60 |
| Travel and Lodging | $1,518.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,570.32 | 2025 | Inspire |
| Acera Surgical, INC. | $388.56 | 2023-2025 | Restrata Wound Matrix |
| Stryker Corporation | $302.73 | 2022-2025 | Nico Myriad Spectra |
| Axogen | $280.84 | 2024-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Kerecis Limited | $159.13 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Regeneron Healthcare Solutions, INC. | $117.31 | 2023 | Dupixent |
| Aerin Medical INC. | $66.76 | 2025 | |
| Daiichi Sankyo INC. | $46.65 | 2023-2024 | Enhertu |
| Pylant Medical | $26.53 | 2022 | |
| Sun Pharmaceutical Industries INC. | $19.76 | 2023 | Odomzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.